Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Clinical data discussed at ERS meeting support use of omalizumab in allergic asthma, rhinitis

Oct. 3, 2001

Clinical trial in asthmatics demonstrates bronchoprotective effect for sildenafil

Oct. 3, 2001

Pivotal trials of Sepracor's rapid- and long-acting bronchodilator initiated

Oct. 3, 2001

Bayer synthesizes new series of integrin antagonists

Oct. 2, 2001

Sankyo presents data on triple NK1/NK2/NK3 antagonist in Berlin

Oct. 2, 2001

Tiotropium superior to salmeterol in key measures in COPD patients

Oct. 2, 2001

Recent patents cover Pfizer's newest PDE4 inhibitors

Oct. 1, 2001

Extensive preclinical and clinical coverage of ciclesonide at ERS

Oct. 1, 2001

Clinical results with efalizumab for asthma reported at ERS meeting

Oct. 1, 2001

Sch-351591 described as promising candidate for respiratory disorders in Edinburgh

Oct. 1, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...